Health Condition 1: J069- Acute upper respiratory infection,unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Children aged 4 to 9 years old. 2.Clinically diagnosed with recurrent respiratory allergic disorders. 3. Parents/guardians willing to provide written informed consent for participation.
Exclusion criteria
Exclusion criteria: 1. Children below 4 years or above 9 years of age. 2.Known cases of congenital heart disease, chronic kidney disease, diabetes, or tuberculosis. 3.Known cases of systemic disorders. 4.Known cases of immunodeficiency disorders. 5.Currently undergoing steroid treatment or immunosuppressive therapy. 6.Participation in any other clinical study within 3 months prior to screening for the present study. 7.Other conditions, which in the opinion of the investigators, render the patient unsuitable for enrolment or could interfere with adherence to the study protocol. 8.Inability or unwillingness of the parent/guardian to adhere to the follow-up schedule or instructions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Reduction in frequency of respiratory allergic episodes. Timepoint: Baseline, end of 6th month | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Changes in immunological markers like IgE, IL6, IL10.Timepoint: Baseline, end of 6th month;2.Improvement in general Health parameters.Timepoint: Every Visit;3.Safety and tolerability of Baljeevan Syrup.Timepoint: Every Visit | — |
Countries
India
Contacts
Dr D Y Patil Deemed to be University, School of Ayurveda, Nerul-Navi Mumbai